70
Participants
Start Date
November 24, 2014
Primary Completion Date
November 12, 2016
Study Completion Date
November 12, 2016
spinal group
plain bupivacaine 0.5%,1.5 ml plus dexmedetomidine 5 μg. once injection.
paravertebral group
plain bupivacaine 0.5%, 0.3 ml (1.5 mg)/kg plus dexmedetomidine 0.5 μg /kg divided between the T2 and T4 levels.
Oncolgy Center, Mansoura University,, Al Mansurah
Alaa Mazy
OTHER